Inicio | Post –authorizacion study on safety and effectiveness of ior®EPOCIM of 3000 UI y 5000 UI in patients with symptomatic anemia associated chronic kidney disease undergoing dialysis.
Publicado clinical_trials Post –authorizacion study on safety and effectiveness of ior®EPOCIM of 3000 UI y 5000 UI in patients with symptomatic anemia associated chronic kidney disease undergoing dialysis. has 2 revisions.
RevisiónEstado
Guardado 28/10/2026 - 2:48pm por CIM
Revisión actual (publicada)
Guardado 28/10/2026 - 2:45pm por CIM
archivadas
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2026 All Rights Reserved.